glp·helper
glphelper.com/ozempic/california/mountain-view
GLP-1 receptor agonistFDA-approved December 2017Rx · Subcutaneous injection · Once weekly

Ozempic® providers &
prescriptions in Mountain View, CA

Verified Ozempic providers in Mountain View, CA. Checked against the NPI registry, sorted by waitlist, not by who pays us.[7]

average Ozempic weight loss →trial-anchored estimate
city providers
37
as of today
median wait
8d
first visit
telehealth
71%
of providers
cash range
$25 to $1,150
monthly
§ 02Provider directory: California
38 of 38 shown

Find an Ozempic provider in California.

Every entry is checked against the NPI registry and the California medical board. Listings are ordered by current waitlist. The provider who can see you fastest appears first. We do not accept payment for placement.

Filter →
Type
Provider
City
Waitlist
Insurance
Browse by California city · /ozempic/california/{city}
§ 03Getting Ozempic in Mountain View
38 providers · Mountain View, CA

How to get Ozempic in Mountain View.

38 GLP-1 prescribers and 7 local resource types are on record for Mountain View, plus 3 nearby towns in the directory.

Prescribers in Mountain View
38 prescribers
38 GLP-1 prescribers in Mountain View, most listed as Internal Medicine, Endocrinology, Diabetes & Metabolism (15), Family Medicine (13) and Internal Medicine (9). Any California-licensed physician, nurse practitioner, or PA can prescribe Ozempic, over video or in person. The nearest towns on record are Sunnyvale (29 providers), Palo Alto (39 providers) and Santa Clara (30 providers).
Around the prescription in Mountain View
7 listed nearby
58 dietitians, 8 nutritionists, 6 gyms, 6 fitness clubs, 6 trainers, 6 physiotherapists and 50 places to move are on record near Mountain View.
Medicaid (weight loss)
Diabetes only
As of April 2026, California Medicaid covers GLP-1s for diabetes but not for weight loss. Employer and private plans can still cover them; that is a plan-design choice, not a state rule.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm California’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for adults with type 2 diabetes, and, by indirect effect, for body weight.

Ozempic is the brand name for semaglutide, a once-weekly subcutaneous injection in the GLP-1 receptor agonist class. It mimics a gut hormone that signals satiety to the brain and slows gastric emptying. In randomized trials it lowered HbA1c by 1.4 to 1.8 percentage points and produced a mean weight loss of 4.5 to 6.4 kg at the 1 mg dose.[2][3]

It is FDA-approved for glycemic control in adults with type 2 diabetes mellitus and for reducing the risk of major cardiovascular events in adults with T2D and established cardiovascular disease. The same molecule, marketed by the same manufacturer as Wegovy, is the FDA-approved formulation for chronic weight management.[1]

For the receptor story in plain English, read how does ozempic work.

Rapid weight loss can change the midface. The mechanism people call ozempic face is in the research notes.

At a glanceNDC 0169-4132
Generic name
semaglutide
Drug class
GLP-1 receptor agonist
Manufacturer
Novo Nordisk
FDA approved
December 2017
Approved use
Type 2 diabetes mellitus (adults)
Off-label use
Weight management (Wegovy is the FDA-approved formulation for obesity)
Administration
Subcutaneous injection · Once weekly
Available doses
0.25 mg · 0.5 mg · 1 mg · 2 mg
Half-life
≈ 7 days
Pregnancy
Discontinue ≥ 2 months before planned pregnancy

Community health · CDC

Weight & metabolic health in Mountain View

Mountain View, California has a population of 82,376 people. The adult obesity rate in Mountain View is an age-adjusted estimate of 21.3%, 7.8 percentage points below the California state rate of 29.1%. Diagnosed diabetes reaches 8.3% of adults in Mountain View. Inactivity, meaning no leisure-time physical activity reported in the past month, affects 17.5% of adults in Mountain View.

of Mountain View adults have obesity
21.3%
diagnosed diabetes
8.3%
no regular physical activity
17.5%

Age-adjusted estimates for Mountain View, community figures, not individual risk. CDC PLACES, 2025 release.

Estimate your weight lossHRT and weight-loss medication
§ 05Support around Ozempic in Mountain View
6 fitness clubs

The prescription is one part. Here is the rest, in Mountain View.

Trials of semaglutide paired the drug with diet counseling and regular activity. Every name below is a real listing near Mountain View, CA, ordered as the registry lists them, never by who pays us.

Fitness clubs and recreation centers

Fitness clubs and recreation centers run classes and pools, an easier start than a weight room.

24 Hour Fitness
GYM
4.0 on Google · 1182 reviews
550 Showers Dr
Website
Transform Fitness Studio - Mountain View
GYM
4.9 on Google · 589 reviews
319 Castro St
Website
F45 Training Mountain View CA
GYM
5.0 on Google · 150 reviews
1350 Grant Rd
Website
NCFIT Mountain View
GYM
4.9 on Google · 109 reviews
112 N Rengstorff Ave
Website
Movement Mountain View
GYM
4.5 on Google · 101 reviews
630 San Antonio Rd
Website
StretchLab Mountain View
FITNESS
4.7 on Google · 64 reviews
555 San Antonio Rd Ste 41
Website

Registered dietitians

A registered dietitian builds the food plan around your prescription. Call to ask about GLP-1 nutrition plans and insurance.

Dima Barghouti, RD
RD
Registered dietitian
1790 Mount Kenya Dr
Call 408-242-0792NPI 1962185132
Natalie Breault, RD
RD
Registered dietitian
2490 Hospital Dr Ste 106
Call 650-695-0955NPI 1750001038
Tamei Chan, RD
RD
Registered dietitian
3801 Miranda Ave
Call 650-493-5000NPI 1104840081
Dorothea Chapa, R.D.,CDE
RD
Registered dietitian
701 E El Camino Real
Call 650-934-7177NPI 1245560754
Jill Christensen, RD
RD
Registered dietitian
3200 Kearney St
Call 510-490-1222NPI 1881671311
Amanda Cooley, RD, IBCLC
RD
Registered dietitian
809 Cuesta Dr
Call 530-219-7880NPI 1912798141
§ 06Clinical evidence
N = 8,416 across SUSTAIN 1 to 7

What the trials actually showed.

We summarize results from the SUSTAIN program, the seven Phase III randomized trials Novo Nordisk submitted to the FDA, and the SUSTAIN-6 cardiovascular outcomes trial. Numbers below are means at the 30-week endpoint, 1 mg weekly dose.

SUSTAIN 1 through 7 compared semaglutide against placebo, sitagliptin, exenatide ER, insulin glargine, and dulaglutide. Semaglutide produced superior HbA1c and body-weight reductions in every active comparator trial.[3]
SUSTAIN endpoint table1 mg / 30 wk
HbA1c reduction
−1.4 to −1.8%
vs. placebo at 30 wk[3]
Weight change
−4.5 to −6.4 kg
mean, 1 mg dose[3]
Major adverse cardiac events
−26%
HR 0.74 vs. placebo[2]
Patients reaching HbA1c <7%
72%
1 mg dose, 30 wk[3]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Ozempic weight loss →mapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in SUSTAIN trials were nausea (15 to 20%), diarrhea (8 to 9%), and vomiting (5 to 9%), all dose-dependent and typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Contraindicated in personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
15 to 20%
mild
Most common; typically dose-dependent and resolves within weeks
Diarrhea
8 to 9%
mild
More frequent during dose escalation
Vomiting
5 to 9%
mild
Reduced by slower titration
Constipation
3 to 7%
mild
Abdominal pain
5 to 7%
moderate
Pancreatitis
<0.3%
serious
Discontinue if confirmed; black-box adjacent
Gallbladder disease
1.5%
serious
Cholelithiasis risk elevated with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated in MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Cash (no insurance)
$950 to $1,150
per month
National pharmacy average, brand-name[6]
Commercial insurance (covered)
$25 to $250
per month copay
Varies by PBM; T2D indication usually covered
Commercial insurance (off-label / weight)
Typically denied
PA required; majority denied for weight indication
Medicare Part D
$0 to $100
per month
T2D covered; weight loss not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial only; eligibility limits apply
Compounded semaglutide
$150 to $400
per month
503A pharmacies; FDA scrutiny ongoing[8]
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Ozempic providers in California

NPI-verified Ozempic (semaglutide) prescribers and clinics, ordered by availability, never by who pays us.

Ozempic in other states

Find NPI-verified Ozempic (semaglutide) doctors, clinics, and pharmacies in the states we cover, ordered by availability, never by who pays us.

Related GLP-1 research
§ 09Frequently asked: Ozempic in California

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Yes. Semaglutide is a federally scheduled prescription drug in all 50 states. A licensed prescriber (MD, DO, NP, or PA) must evaluate you before issuing a prescription. No state permits pharmacist-initiated prescribing of GLP-1s.[1]